4 Sc AG Stock Deutsche Boerse AG
Equities
DE0005753818
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2022 | 436K 466K | Sales 2023 | 304K 325K | Capitalization | 89.51M 95.73M |
---|---|---|---|---|---|
Net income 2022 | -14M -14.97M | Net income 2023 | -8M -8.56M | EV / Sales 2022 | -4.31 x |
Net cash position 2022 | 14.82M 15.86M | Net cash position 2023 | 5.22M 5.58M | EV / Sales 2023 | 277 x |
P/E ratio 2022 |
-0.9
x | P/E ratio 2023 |
-10.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 26.68% |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |